医学
败血症
免疫疗法
免疫抑制
器官功能障碍
免疫学
重症监护
免疫系统
重症监护医学
复苏
外科
作者
Lihua Dong,Juan Lyu,Lili Ding,Zhongmin Liu
出处
期刊:PubMed
[National Institutes of Health]
日期:2017-02-01
卷期号:29 (2): 184-187
被引量:2
标识
DOI:10.3760/cma.j.issn.2095-4352.2017.02.019
摘要
OBJECTIVE: Sepsis is a life-threatening organ dysfunction caused by dysregulated host responses to infection. Despite decades of research, it remains the leading cause of death in intensive care units (ICUs). None of the current treatment, including antibiotics, organ protection and liquid resuscitation, is specifically effective for sepsis. Immunosuppression is one of the currently accepted pathogenesis and immunotherapy is one of the hot spot of current sepsis research. Immune related treatments include restricting the release of pathogen toxin and its removal, controlling the excessive inflammatory reaction and apoptosis inhibition, etc. Numerous pre-clinical studies using immunomodulatory agents such as interleukin-7 (IL-7), anti-programmed cell death-1 (PD-1) antibody and others, have demonstrated reversal of T cell dysfunction and improved survival resulting from reviewing recent advances in immunotherapy of sepsis. Therefore, immunotherapy may be a new way of sepsis treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI